NATICK, MA – April 24, 2023 –   (Business Wire) Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced the appointment of Myla Lai-Goldman, MD, to its Board of Directors. “Myla’s visionary...

NATICK, MA – April 03, 2023 –   (Business Wire) Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced it has closed a $41 million Series A financing round. The oversubscribed financing was...

NATICK, MA – March 23, 2023 –   (Business Wire) Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced that it has added two senior executives as the Company transitions from research to...

NATICK, MA – February 15, 2023 –   (Business Wire) Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced that Dawn Mattoon, PhD, has assumed the role of Chief Executive Officer and a...

NATICK, MA – July 11, 2022 –   Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced the appointment of experienced biotechnology executive, Dawn Mattoon, PhD, as Chief Operating Officer,...

Mercy Halo Data Demonstrates Promise of Novel Extracellular Vesicle Biomarker-Based Approach for Early Cancer Detection Natick, MA – May 27, 2022 - Mercy BioAnalytics™, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer,...